It is a multinational study investigating the safety and efficacy of biphasic insulin aspart 30/70 (BIAsp 30) in the routine management of patients with Type 2 diabetes mellitus. Five published ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback